WallStreetZenWallStreetZen

NASDAQ: INM
Inmed Pharmaceuticals Revenue

OverviewEarningsRevenue
DividendOwnership
Inmed Pharmaceuticals revenue was $4.94M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2025) ending on Jun 30, 2025 was $1.3M, up 3.4% from last quarter. For the last reported fiscal year 2025 ending Jun 30, 2025, INM annual revenue was $4.9M, with 7.5% growth year-over-year.

INM past revenue growth

How has INM's revenue growth performed historically?

Company
7.5%
Industry
150.53%
Market
20.47%
INM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
INM's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
INM's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

INM revenue history

Current Revenue
$4.9M
Current Earnings
-$8.2M
Current Profit Margin
-165.1%

Be the first to know when INM announces revenue.

INM Revenue History By Year

INM Yearly RevenueINM RevenueINM ChangeINM Revenue Growth
2025-06-30$4.94M$344.90k+7.50%
2024-06-30$4.60M$462.17k+11.18%
2023-06-30$4.14M$3.05M+279.61%
2022-06-30$1.09MN/AN/A
2021-06-30$0.00N/AN/A
2020-06-30$0.00N/AN/A
2019-06-30$0.00N/AN/A

1 of 1

Inmed Pharmaceuticals Revenue FAQ

What was INM's revenue last quarter?

On Invalid Date, Inmed Pharmaceuticals (NASDAQ: INM) reported Q2 2025 revenue of $1.30 million up 1.69% year over year. In the same quarter last year, Inmed Pharmaceuticals's revenue was $1.28 million.

What was Inmed Pharmaceuticals's revenue in 2025?

Inmed Pharmaceuticals's annual revenue for the twelve months ending Jun 30, 2025 was $4.94 million, a 7.5% increase year over year.

How much does Inmed Pharmaceuticals make in a day?

Based on Inmed Pharmaceuticals annual revenue for the past five years, INM makes an average of $8,090.61 per day.

What was Inmed Pharmaceuticals's annual revenue growth in the past year?

As of Q4 2025, Inmed Pharmaceuticals's revenue has grown 7.5% year over year. This is 143.03 percentage points lower than the US Biotechnology industry revenue growth rate of 150.53%. Inmed Pharmaceuticals's revenue in the past year totaled $4.94 million.

How much does Inmed Pharmaceuticals make in a year?

Inmed Pharmaceuticals's revenue by year for the past five years is:
  • Inmed Pharmaceuticals's revenue for the twelve months ending Jun 30, 2025 was $4.94 million, a 7.5% increase year over year.
  • Inmed Pharmaceuticals's annual revenue for Jun 30, 2024 was $4.60 million, a 11.18% increase from 2023.
  • Inmed Pharmaceuticals's annual revenue for 2023 was $4.14 million, a 279.61% increase from 2022.
  • Inmed Pharmaceuticals's annual revenue for 2022 was $1.09 million, a Infinity% increase from 2021.
  • Inmed Pharmaceuticals's annual revenue for 2021 was $0.00, a N/A decrease from 2020.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.